Mind Medicine Inc (NASDAQ: MNMD) closed the day trading at $5.35 down -3.78% from the previous closing price of $5.56. In other words, the price has decreased by -$0.21 from its previous closing price. On the day, 2066325 shares were traded.
Ratios:
For a better understanding of MNMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 3.85. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on December 05, 2023, initiated with a Buy rating and assigned the stock a target price of $9.
On November 16, 2022, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $5.RBC Capital Mkts initiated its Outperform rating on November 16, 2022, with a $5 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 26 when Barrow Robert sold 13,237 shares for $3.63 per share. The transaction valued at 48,050 led to the insider holds 596,721 shares of the business.
Karlin Dan sold 6,774 shares of MNMD for $24,590 on Dec 26. The Chief Medical Officer now owns 365,030 shares after completing the transaction at $3.63 per share. On Dec 26, another insider, Greenway Schond L., who serves as the Chief Financial Officer of the company, sold 5,652 shares for $3.63 each. As a result, the insider received 20,517 and left with 216,617 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 229.26M and an Enterprise Value of 125.63M.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $5.66, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is 4.06, while the 200-Day Moving Average is calculated to be 3.67.
Shares Statistics:
Over the past 3-months, MNMD traded about 714.88K shares per day on average, while over the past 10 days, MNMD traded about 891.76k shares per day. A total of 37.98M shares are outstanding, with a floating share count of 26.01M. Insiders hold about 7.63% of the company’s shares, while institutions hold 17.00% stake in the company. Shares short for MNMD as of Feb 15, 2024 were 3.43M with a Short Ratio of 4.80, compared to 3.22M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.55% and a Short% of Float of 8.64%.
Earnings Estimates
Current recommendations for the stock of the company come from 7 analysts. On average, analysts expect EPS of -$0.46 for the current quarter, with a high estimate of -$0.29 and a low estimate of -$0.57, while EPS last year was -$0.16. The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.28 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$1.95 and -$2.42 for the fiscal current year, implying an average EPS of -$2.27. EPS for the following year is -$1.87, with 7 analysts recommending between -$1.14 and -$2.3.
